SWALES HEALTH LTDActive

Company number 09101373Private limited companyIncorporated 2014

Key figures

£59,821-30.5%
Net assets 2024/25
+31.8%
Average annual growth 2019/20–2024/25
025 k50 k75 k100 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, SWALES HEALTH LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand—————
Total assets131,361179,233215,236160,548116,397
Total liabilities78,009124,109119,90774,51656,576
Net assets / total equity52,63254,40495,32986,03259,821
Average number of employees36088

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

96040

As described in the company's latest filed accounts.

Summary: SWALES HEALTH LTD

Company

SWALES HEALTH LTD is a private limited company registered with Companies House under company number 09101373. It was incorporated on 24 Jun 2014. Its status is active. The registered office is in Newcastle upon tyne (NE7). Its nature of business (SIC 2007) is physical well-being activities (96040).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were £59,821, down 30.5% on the previous year. Total assets were £116,397 and total liabilities £56,576. The company had an average of 8 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 10 May 2027.